U.S. Approves Updated COVID-19 Vaccines for Fall and Winter
The U.S. has approved updated COVID-19 vaccines for the fall and winter, offering protection against the latest subvariants. The FDA has authorized these vaccines for those 12 years and older, and the CDC recommends them for children aged 6 months through 11 years. However, as of May 2023, only around 18% of eligible Americans have received the bivalent vaccine.
The new boosters target the Omicron XBB.1.5 variant and its close relatives, Eris and Pirola. They should provide protection during the upcoming respiratory season when multiple viruses, including the coronavirus, seasonal flu, and RSV, are circulating simultaneously.
The CDC advises COVID-19 vaccination for children aged 6 months and older, with specific schedules depending on age. For children under 12, vaccination is particularly recommended for those with risk factors. However, a recent advisory panel suggests shared decision-making with a healthcare provider before vaccinating children.
Pfizer, Moderna, and Novavax have reported that their updated vaccines work against newer variants. The federal government is no longer providing the vaccines for free to all Americans, but many will still have access at no cost through insurance or government programs.
The updated COVID-19 vaccines are now available, offering protection against the latest subvariants. The CDC recommends these vaccines for everyone 6 months and older. While the federal government is no longer providing free vaccines to all, many Americans can still access them at no cost through insurance or government programs.
